Nihon Kohden Of Japan To Distribute Cyberonics Device If Approved
This article was originally published in PharmAsia News
Executive SummaryJapan's Nihon Kohden has agreed with U.S.-based Cyberonics to distribute the Houston company's VNS Therapy Systems in Japan. The deal is subject to approval of the implanted device for vagus nerve stimulation by Japanese authorities. The U.S. FDA already has approved VNS for treating refractory epilepsy and depression resistant to other treatments. Cyberonics began distributing VNS in China last year. (Click here for more
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.